(Q73567640)
Statements
High-dose interferon alfa-2b does not diminish antibody response to GM2 vaccination in patients with resected melanoma: results of the Multicenter Eastern Cooperative Oncology Group Phase II Trial E2696 (English)
J M Kirkwood
J Ibrahim
D H Lawson
M B Atkins
S S Agarwala
K Collins
R Mascari
D M Morrissey